Martin Bloom - Emeren Independent Chairman of the Board

SOL Stock  USD 1.91  0.09  4.95%   

Chairman

Mr. Martin Bloom is Independent Chairman of the Board of ReneSola Ltd., since September 2006. He was an independent director since July 2006 and has served as the chairman of the board since September 2006. Mr. Bloom is also the chairman of the audit committee and a member of the compensation committee and corporate governance and nominating committee of our board of directors. In addition, he was on the board of Intelligent Energy, a British fuel cell company, since June 2012. Mr. Bloom has almost 40 years of experience in strategic partnering, technology commercialization and business strategy. He has built businesses in the U.S., Europe and China. In 2005, Mr. Bloom was appointed to serve as the UK chairman of the ChinaUK VC Joint Working Group, launched by the thenChancellor of the United Kingdom, Gordon Brown, in February 2005, to foster collaboration between the VC and private equity industries in China and the United Kingdom. Mr. Bloom worked at Coopers Lybrand from 1996 to 1997 and was the project manager of a series of technology transfer schemes between the United Kingdom and Japan on behalf of the Department of Trade Industry of the United Kingdom from 1992 to 1997. Mr. Bloom worked as a corporate strategist at Unilever between 1973 and 1981 since 2016.
Age 68
Tenure 8 years
Address 100 First Stamford Place, Stamford, CT, United States, 06902
Phone347 577 9055
Webhttps://emeren.com
Bloom has a bachelor’s degree with honors in economics from the University of Southampton and a master’s degree in the history of science jointly from Imperial College and University College, London.

Emeren Management Efficiency

The company has Return on Asset of (0.0104) % which means that on every $100 spent on assets, it lost $0.0104. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0314) %, meaning that it generated no profit with money invested by stockholders. Emeren's management efficiency ratios could be used to measure how well Emeren manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to -0.02 this year. Return On Capital Employed is expected to rise to -0.002 this year. At this time, Emeren's Other Assets are quite stable compared to the past year. Net Tangible Assets is expected to rise to about 431.3 M this year, although the value of Return On Tangible Assets are projected to rise to (0.02).
The company has 58.91 M in debt with debt to equity (D/E) ratio of 0.11, which may show that the company is not taking advantage of profits from borrowing. Emeren Group has a current ratio of 8.99, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Emeren until it has trouble settling it off, either with new capital or with free cash flow. So, Emeren's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Emeren Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Emeren to invest in growth at high rates of return. When we think about Emeren's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 7 records

CHAIRMAN Age

Jeffrey PeckiSun Inc
52
Thomas WernerSunPower
64
Peter FaricySunPower
58
William BergerSunnova Energy International
50
Xiaohua QuCanadian Solar
60
Xiande LiJinkoSolar Holding
49
Edward FensterSunrun Inc
47
ReneSola Ltd, through its subsidiaries, develops, builds, operates, and sells solar power projects in the United States, Canada, Europe, and internationally. ReneSola Ltd was founded in 2005 and is headquartered in Stamford, Connecticut. Renesola operates under Solar classification in the United States and is traded on New York Stock Exchange. It employs 164 people. Emeren Group (SOL) is traded on New York Stock Exchange in USA. It is located in 100 First Stamford Place, Stamford, CT, United States, 06902 and employs 25 people. Emeren is listed under Construction & Engineering category by Fama And French industry classification.

Management Performance

Emeren Group Leadership Team

Elected by the shareholders, the Emeren's board of directors comprises two types of representatives: Emeren inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Emeren. The board's role is to monitor Emeren's management team and ensure that shareholders' interests are well served. Emeren's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Emeren's outside directors are responsible for providing unbiased perspectives on the board's policies.
Chee Cheah, Chief Europe
Suzanne Wilson, Secretary Board
Himanshu Shah, Director
Wenjun Li, President of China Region, Director
Xin Wang, Compliance Director
Mac Moore, Executive America
KaiKai Zhang, Executive China
Xinhan Li, Vice President of Investment, Director
Weicheng Chen, Independent Director
Kevin Chen, President of North America Region
Josef Kastner, Chief Executive Officer of Europe Projects
Fei Wang, Vice Finance
Martin Bloom, Independent Chairman of the Board
John Ewen, Chief Executive Officer of North America
Kaiheng Feng, Director
Yuanyuan Ma, Director
Jake Snow, Human Director
Julia Xu, Independent Director
Yumin Liu, Chief Executive Officer
Wee Tan, Independent Director
Johnny Pan, Investor Relations
Ella Li, Investor Relations
Ke Chen, Chief Financial Officer, Director
Sam Feng, Director
Rebecca Shen, Investor Contact

Emeren Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Emeren a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

When determining whether Emeren Group is a strong investment it is important to analyze Emeren's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Emeren's future performance. For an informed investment choice regarding Emeren Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Emeren Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Emeren Stock analysis

When running Emeren's price analysis, check to measure Emeren's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emeren is operating at the current time. Most of Emeren's value examination focuses on studying past and present price action to predict the probability of Emeren's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emeren's price. Additionally, you may evaluate how the addition of Emeren to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Bonds Directory
Find actively traded corporate debentures issued by US companies
Is Emeren's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emeren. If investors know Emeren will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emeren listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
3.42
Earnings Share
(0.16)
Revenue Per Share
1.852
Quarterly Revenue Growth
1.128
Return On Assets
(0.01)
The market value of Emeren Group is measured differently than its book value, which is the value of Emeren that is recorded on the company's balance sheet. Investors also form their own opinion of Emeren's value that differs from its market value or its book value, called intrinsic value, which is Emeren's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emeren's market value can be influenced by many factors that don't directly affect Emeren's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emeren's value and its price as these two are different measures arrived at by different means. Investors typically determine if Emeren is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emeren's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.